Physician profile
Christopher D Merifield
NPI 1811978976
$5,164.70
in general payments reported to CMS, 2019-2025
10 companies · $281 in 2025
The $281 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,005 · 2020: $1,111 · 2021: $1,050 · 2022: $531 · 2023: $727 · 2024: $461 · 2025: $281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,468.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,468.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $2,323.59 | 2019-2023 | Senza |
| Medtronic USA, INC. | $856.96 | 2019-2020 | |
| Abbott Laboratories | $404.63 | 2019-2021 | |
| Painteq LLC | $339.82 | 2023-2024 | Painteq |
| Vertos Medical, INC. | $283.10 | 2023-2024 | Mild Device Kit |
| Globus Medical, INC. | $280.98 | 2025 | Affix, Senza |
| Nalu Medical, INC. | $222.03 | 2024 | Nalu Neurostimulation System |
| Stimwave Technologies Incorporated | $186.91 | 2019 | |
| Boston Scientific Corporation | $154.76 | 2022 | |
| Amgen INC. | $111.92 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Merifield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.